Research

Read how cancer survivorship research reveals more about the late effects of treatment on children – and how the data can paint a more complete picture.

Researchers have promising information that ruxolitinib may help treat a devastating auto-immune disorder.

Improving understanding of drugs and how the body reacts to them - - Read how science is improving understanding of genes and medication.

Read how this protein, called a chaperone, does more than simply monitor the intracellular dance of protein folding – it protects them from going awry.

Read how extremely rare genetic childhood diseases offer clues about understanding neurodegenerative disorders common with aging.

Powerful cancer data portal gets an upgrade to identify the genetic culprit for inherited cancer and possibly other genetic diseases.

Two friends and research colleagues are looking at different stages of the immune response to pave the way for enhanced cancer treatments.

High science calls on Star Wars character as a potential ally against Alzheimer’s disease.

St. Jude is testing adult cancer drug prexasertib in children with recurrent or refractory medulloblastoma to inhibit checkpoint kinase chk1/2.

An agreement between one U.S. hospital and two Chinese hospitals in 1991 has completely changed global pediatric cancer care.